SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as traders debate the stock's post-earnings volatility, with many attributing the price decline to market maker manipulation and option-killing tactics despite strong financial results and an expanding AI backlog. While some investors view the pullback as a buying opportunity, others express frustration over the stock's inability to maintain gains or criticize its debt and cash flow position.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo shares are under pressure as traders react to the company launching a new 1 billion dollar at-the-market equity offering program, fueling widespread concerns about shareholder dilution. While some investors view the price decline as a buying opportunity, citing the company's long-term potential in AI-driven energy demand, many in the community are expressing frustration over the persistent dilution and speculative nature of the stock.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power shares are seeing significant volatility as traders react to a wide revenue miss and a concurrent announcement of a new at-the-market equity offering. While some participants view the pullback as a buying opportunity based on long-term nuclear energy demand, others are expressing frustration over the company's limited commercial progress and continued capital raising efforts.

Alliance Entertainment Holding Corp. engages in the distribution of music, movies, and consumer electronics. It distributes its physical media, entertainment products, hardware, and accessories through an established multi-channel strategy. The company was founded in 1990 and is headquartered in Plantation, FL.

Alliance Entertainment Holding Corporation - Ordinary Shares - Class A

AENT is trending as traders speculate on potential stock price recovery and discuss its low float status. Investors are debating the company's long-term prospects, focusing on its role in physical media distribution and collectibles, despite frustration over recent volatility.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is trending as traders debate the sustainability of its recent rally, with many expressing skepticism regarding the stock's valuation and citing concerns over insider selling and large bond offerings. While bulls point to robust demand for AI-optimized servers and positive analyst coverage, bears suspect price manipulation and warn of a potential pullback.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders speculate on the timing and results of upcoming maintenance study data for its obesity candidate, VK2735. While some investors remain optimistic about potential buyout interest and the drug's efficacy, others express frustration over the company's communication style and lack of immediate news.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending due to a strong fiscal third-quarter earnings report that featured triple-digit revenue growth and significantly raised full-year guidance, fueled by accelerating demand for AI data center and grid infrastructure. While some traders express caution over secondary equity offerings and lock-up expirations, others remain bullish on the company's massive order backlog and critical role in the power infrastructure buildout.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as traders debate the company's valuation and potential turnaround, with discussion focused on heavy insider buying and speculation regarding the possible sale of the STAR debit network. While some investors view the current price as a long-term value opportunity, others express significant frustration over management execution and weak performance, maintaining a bearish outlook until there is clear evidence of a recovery.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake shares are facing significant downward pressure following the release of Phase 3 IZAR-1 trial data, which investors feel failed to demonstrate the expected best-in-class efficacy for sonelokimab in psoriatic arthritis, compounded by investor frustration over a new mixed shelf filing that suggests potential future dilution.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending following a record-breaking second-quarter earnings report that exceeded analyst expectations and led to positive analyst price target revisions. While some traders express frustration over macro headwinds like geopolitical tensions and interest rate volatility, many remain bullish on the company's long-term growth potential and undervalued position relative to its fintech peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phreesia (PHR) Q2 2027 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Why Phreesia Stock Got Knocked Down Today

Key PointsThis added to lingering negative sentiment following the company's latest earnings release...

Why Phreesia Stock Tumbled Today

Key PointsAlthough its net income rose sharply, analysts expected better...

These Analysts Revise Their Forecasts On Phreesia After Q2 Results

Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10.read more...

Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Transcript: Phreesia Q2 2027 Earnings Conference Call

Phreesia (NYSE:PHR) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below.
This content is powered by Benzinga APIs. Forread more...

Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates

Phreesia (PHR) delivered earnings and revenue surprises of -72.73% and -0.13%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Phreesia Announces Second Quarter Fiscal 2027 Results

Phreesia, Inc. (NYSE: PHR) (Phreesia or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. Phreesia delivered a solid fiscal second quarter, with revenue growth and profitability expansion in line with our expectations. We generated positive...

Veeva Systems (VEEV) Q2 Earnings and Revenues Beat Estimates

Veeva (VEEV) delivered earnings and revenue surprises of +5.86% and +2.64%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates

NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of -100.00% and -54.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Phreesia Inc

Why PEPG, SGMO, PHR Are Among Top Premarket Losers Today

Equity

Bearish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.12	--	--	N/A
Q2 '26	$0.03	$0.03	-3.14%	MISSED
Q1 '26	$0.01	$0.05	337.06%	BEAT
Q4 '25	$0.06	$0.02	-66.40%	MISSED
Q3 '25	-$0.00	$0.07	19544.44%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

PHR Earnings

Latest Earnings Results: Q2 '26

Historical Earnings